Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

8.86
-1.7350-16.38%
Pre-market: 8.72-0.1406-1.59%09:09 EDT
Volume:1.00M
Turnover:9.41M
Market Cap:171.36M
PE:-1.46
High:10.72
Open:10.60
Low:8.85
Close:10.60
52wk High:20.56
52wk Low:7.12
Shares:19.34M
Float Shares:17.42M
Volume Ratio:1.58
T/O Rate:5.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.68
PE(LYR):-1.50

Loading ...

Corbus Pharmaceuticals Holdings Inc - to Initiate Registrational Study for Crb-701 in Second-Line Hnscc This Summer

THOMSON REUTERS
·
May 21

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 Asco Crb-701 Data Conference Call

THOMSON REUTERS
·
May 21

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

GlobeNewswire
·
May 21

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 21

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
May 20

Corbus Pharmaceuticals Holdings Inc. Stock Falls 9.8%, Underperforms Peers

Dow Jones
·
May 19

Corbus Pharmaceuticals (CRBP) Receives a Buy from LifeSci Capital

TIPRANKS
·
May 16

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 15

Corbus Pharmaceuticals Adds Independent Director Amid Governance Updates

TIPRANKS
·
May 14

Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors

THOMSON REUTERS
·
May 14

Corbus Pharmaceuticals Price Target Maintained With a $45.00/Share by Guggenheim

Dow Jones
·
May 13

Oppenheimer Adjusts Price Target on Corbus Pharmaceuticals to $54 From $57, Maintains Outperform Rating

MT Newswires Live
·
May 13

Wedbush Remains a Buy on Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
May 13

Corbus Pharma CEO presents at RBC Capital Markets Global Healthcare Conference

Reuters
·
May 13

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 13

Corbus Pharmaceuticals price target lowered to $33 from $36 at Jefferies

TIPRANKS
·
May 13

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 13

Corbus Pharmaceuticals reports Q1 EPS ($1.23), consensus ($1.22)

TIPRANKS
·
May 13

Corbus Pharmaceuticals Q1 EPS $(1.23) Misses $(1.22) Estimate

Benzinga Earnings
·
May 12

Corbus Q1 FY26 net loss widens to $23 million; operating expenses rise to $24.3 million

Reuters
·
May 12